Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute and Associate Editor for Breast Cancer at ESMO Open, shared a post by Herbert Loong on X, adding:
”Thanks for highlighting our review on ADC toxicities Herbert Loong. We have a ways to go to fully realize the dream of the magic bullet, but with through education, proactive management and continued innovation, ADCs are getting every day safer!”
Quoting Herbert Loong‘s post:
“Having post IASLC WCLC25 blues? Happy to share a few slides from our session on navigating ADC toxicities. Credits to Paolo Tarantino, Sara Tolaney and colleagues for their excellent review on ADCs published in Nature Portfolio. Check it out here:
Title: Optimizing the safety of antibody-drug conjugates for patients with solid tumours
Authors: Paolo Tarantino, Biagio Ricciuti, Shan M. Pradhan, Sara M. Tolaney”
More posts featuring ADCs’ on OncoDaily.
